RNA sequencing or RNA-seq is a highly sensitive tool which measures the gene expression across the transcriptome accurately and provides visibility to undetected changes occurring in various disease states. This technique can detect gene fusions, novel transcripts, indels, and single-nucleotide variants without the requirement of transcript-specific probes. 1. Micromarkets are segments and subsegments of the NGS-based RNA-seq market. 2. RoW includes Latin America, the Middle East, and Africa. 3. Core competencies of the companies are captured in terms of their key developments and strategies adopted to maintain their market positions.